Sars-Cov2 S2 Clone

Rabbit anti-SARS-CoV2 S2-C pAb
0374-001 IBT Bioservices 100 ug 325 EUR
Description: Affinity-purified rabbit polyclonal antibody reactive to SARS-CoV-2 Spike protein S2 subunit C-terminus

Human IgG antibody Laboratories manufactures the sars-cov2 s2 clone reagents distributed by Genprice. The Sars-Cov2 S2 Clone reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Clone. Other Sars-Cov2 products are available in stock. Specificity: Sars-Cov2 Category: S2 Group: Clone

SARS-CoV2-N-Antibody
EnoGene N/A 276.5 EUR
Description: N/A

SARS-Cov2-NP3-Antibody
EnoGene N/A 276.5 EUR
Description: N/A

SARS-Cov2-NP3-Antibody
EnoGene N/A 276.5 EUR
Description: N/A

SARS-Cov2-NP3-Antibody
EnoGene 100 μl 276.5 EUR
Description: N/A

SARS-Cov2-NP2-Antibody
EnoGene N/A 276.5 EUR
Description: N/A

SARS-Cov2-NP2-Antibody
EnoGene N/A 276.5 EUR
Description: N/A

SARS-Cov2-NP1-Antibody
EnoGene N/A 276.5 EUR
Description: N/A

Clone information

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1A6]
SD9785-002mg ProSci 0.02 mg 253.22 EUR
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1A6]
SD9785-01mg ProSci 0.1 mg 723.62 EUR
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1B8]
SD9787-002mg ProSci 0.02 mg 253.22 EUR
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1B8]
SD9787-01mg ProSci 0.1 mg 723.62 EUR
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1G5]
SD9789-002mg ProSci 0.02 mg 253.22 EUR
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1G5]
SD9789-01mg ProSci 0.1 mg 723.62 EUR
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1A9]
SD9791-002mg ProSci 0.02 mg 253.22 EUR
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody [P1A9]
SD9791-01mg ProSci 0.1 mg 723.62 EUR
Description: N/A

SARS-CoV-2 (COVID-19) Spike S2 Antibody (biotin)
9123-biotin-002mg ProSci 0.02 mg 229.7 EUR
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV-2 (COVID-19) Spike S2 Antibody (biotin)
9123-biotin-01mg ProSci 0.1 mg 594.26 EUR
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV2 FL Spike Protein
0573-001 IBT Bioservices 100 ug 395 EUR

SARS-CoV-2 (COVID-19) S2 Recombinant Protein Liquid
ICOV2S2R100UG Innovative research each 753 EUR
Description: SARS-CoV-2 (COVID-19) S2 Recombinant Protein Liquid

SARS-Cov2-Neutralizing-Antibody(Spike)
E28F03095-100ug EnoGene N/A 444.44 EUR
Description: N/A

SARS-Cov2-Neutralizing-Antibody(Spike)
E28F03095-1mg EnoGene N/A 1777.78 EUR
Description: N/A

SARS S2 [His]
DAG1862 Creative Diagnostics 500 ug 3034.8 EUR

SARS MERS S2
sars-053 ProSpec Tany 2µg 60 EUR
Description: Recombinant SARS MERS Spike S2

SARS-CoV-2 (COVID-19) Spike S2 ECD Recombinant Protein
10-115 ProSci 0.1 mg 651.3 EUR
Description: SARS-CoV-2 (COVID-19) Spike S2 ECD Recombinant Protein